rs201825284

Variant summary

Our verdict is Likely benign. The variant received -3 ACMG points: 0P and 3B. BP4_ModerateBS1_Supporting

The NM_001244008.2(KIF1A):​c.4781C>T​(p.Ser1594Leu) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000176 in 1,610,976 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Synonymous variant affecting the same amino acid position (i.e. S1594S) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.00047 ( 1 hom., cov: 33)
Exomes 𝑓: 0.00015 ( 1 hom. )

Consequence

KIF1A
NM_001244008.2 missense

Scores

11
8

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:5B:1

Conservation

PhyloP100: 7.45

Publications

4 publications found
Variant links:
Genes affected
KIF1A (HGNC:888): (kinesin family member 1A) The protein encoded by this gene is a member of the kinesin family and functions as an anterograde motor protein that transports membranous organelles along axonal microtubules. Mutations at this locus have been associated with spastic paraplegia-30 and hereditary sensory neuropathy IIC. Alternatively spliced transcript variants encoding distinct isoforms have been described. [provided by RefSeq, Apr 2012]
KIF1A Gene-Disease associations (from GenCC):
  • intellectual disability, autosomal dominant 9
    Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), G2P
  • syndromic intellectual disability
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • neuropathy, hereditary sensory, type 2C
    Inheritance: AR Classification: DEFINITIVE, STRONG, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, G2P
  • hereditary spastic paraplegia 30
    Inheritance: AR, AD Classification: STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, Orphanet
  • autosomal dominant non-syndromic intellectual disability
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • PEHO syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • hereditary sensory and autonomic neuropathy type 2
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -3 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.07873595).
BS1
Variant frequency is greater than expected in population amr. GnomAd4 allele frequency = 0.000473 (72/152330) while in subpopulation AMR AF = 0.00294 (45/15310). AF 95% confidence interval is 0.00226. There are 1 homozygotes in GnomAd4. There are 43 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check. Existence of Clinvar submissions makes me limit the strength of this signal to Supporting

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
KIF1ANM_001244008.2 linkc.4781C>T p.Ser1594Leu missense_variant Exon 45 of 49 ENST00000498729.9 NP_001230937.1 Q12756-3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
KIF1AENST00000498729.9 linkc.4781C>T p.Ser1594Leu missense_variant Exon 45 of 49 5 NM_001244008.2 ENSP00000438388.1 Q12756-3

Frequencies

GnomAD3 genomes
AF:
0.000466
AC:
71
AN:
152212
Hom.:
1
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.000338
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00294
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.000384
Gnomad SAS
AF:
0.000207
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000132
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.000255
AC:
62
AN:
242990
AF XY:
0.000241
show subpopulations
Gnomad AFR exome
AF:
0.000336
Gnomad AMR exome
AF:
0.000674
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.000338
Gnomad FIN exome
AF:
0.000146
Gnomad NFE exome
AF:
0.0000910
Gnomad OTH exome
AF:
0.000339
GnomAD4 exome
AF:
0.000145
AC:
212
AN:
1458646
Hom.:
1
Cov.:
31
AF XY:
0.000138
AC XY:
100
AN XY:
725396
show subpopulations
African (AFR)
AF:
0.000448
AC:
15
AN:
33468
American (AMR)
AF:
0.000539
AC:
24
AN:
44512
Ashkenazi Jewish (ASJ)
AF:
0.0000767
AC:
2
AN:
26078
East Asian (EAS)
AF:
0.000252
AC:
10
AN:
39654
South Asian (SAS)
AF:
0.000268
AC:
23
AN:
85664
European-Finnish (FIN)
AF:
0.000134
AC:
7
AN:
52124
Middle Eastern (MID)
AF:
0.000174
AC:
1
AN:
5750
European-Non Finnish (NFE)
AF:
0.000112
AC:
125
AN:
1111138
Other (OTH)
AF:
0.0000830
AC:
5
AN:
60258
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.460
Heterozygous variant carriers
0
12
24
37
49
61
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000473
AC:
72
AN:
152330
Hom.:
1
Cov.:
33
AF XY:
0.000577
AC XY:
43
AN XY:
74490
show subpopulations
African (AFR)
AF:
0.000337
AC:
14
AN:
41576
American (AMR)
AF:
0.00294
AC:
45
AN:
15310
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.000578
AC:
3
AN:
5190
South Asian (SAS)
AF:
0.000207
AC:
1
AN:
4830
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10622
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.000132
AC:
9
AN:
68010
Other (OTH)
AF:
0.00
AC:
0
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
4
7
11
14
18
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000180
Hom.:
0
Bravo
AF:
0.000404
TwinsUK
AF:
0.000270
AC:
1
ALSPAC
AF:
0.000519
AC:
2
ESP6500AA
AF:
0.000504
AC:
2
ESP6500EA
AF:
0.000120
AC:
1
ExAC
AF:
0.000258
AC:
31
Asia WGS
AF:
0.000577
AC:
2
AN:
3478

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:5Benign:1
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Uncertain:2
Jan 22, 2025
GeneDx
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Reported in a patient in the published literature with caudal regression syndrome who had another KIF1A variant on the opposite allele (in trans); however, the patient also had variants in two other genes that may have been responsible for the phenotype (PMID: 28007035); Identified heterozygous in a patient with congenital spastic paraplegia, intellectual disability, epilepsy, microcephaly, and brain abnormalities in published literature; however, familial segregation information was not available (PMID: 32737135); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Also known as p.(S1594L); This variant is associated with the following publications: (PMID: 28007035, 32737135) -

Jul 18, 2023
Mayo Clinic Laboratories, Mayo Clinic
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

BS2 -

not specified Uncertain:1
Jul 29, 2015
Genetic Services Laboratory, University of Chicago
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Inborn genetic diseases Uncertain:1
Oct 13, 2021
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.4478C>T (p.S1493L) alteration is located in exon 43 (coding exon 42) of the KIF1A gene. This alteration results from a C to T substitution at nucleotide position 4478, causing the serine (S) at amino acid position 1493 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Hereditary spastic paraplegia Uncertain:1
Mar 01, 2020
Genome Diagnostics Laboratory, The Hospital for Sick Children
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Neuropathy, hereditary sensory, type 2C;C5235139:Hereditary spastic paraplegia 30;C5393830:Intellectual disability, autosomal dominant 9 Benign:1
Jan 17, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.097
BayesDel_addAF
Benign
-0.20
T
BayesDel_noAF
Benign
-0.16
CADD
Pathogenic
28
DANN
Uncertain
1.0
DEOGEN2
Uncertain
0.51
D;.;.;.;.;.;.;D;.;.;.;.;.;.
Eigen
Benign
0.18
Eigen_PC
Uncertain
0.22
FATHMM_MKL
Uncertain
0.92
D
LIST_S2
Uncertain
0.97
.;D;D;D;D;D;.;D;D;D;D;D;D;D
M_CAP
Uncertain
0.14
D
MetaRNN
Benign
0.079
T;T;T;T;T;T;T;T;T;T;T;T;T;T
MetaSVM
Benign
-0.32
T
MutationAssessor
Uncertain
2.3
M;.;.;.;.;.;.;M;.;.;.;.;.;.
PhyloP100
7.5
PrimateAI
Uncertain
0.67
T
PROVEAN
Uncertain
-3.6
.;D;.;.;.;.;.;.;.;.;.;.;.;.
REVEL
Uncertain
0.30
Sift
Uncertain
0.024
.;D;.;.;.;.;.;.;.;.;.;.;.;.
Sift4G
Benign
0.090
.;T;.;.;.;.;.;.;.;.;.;.;.;.
Polyphen
0.17
B;.;.;.;.;.;.;B;.;.;.;.;.;.
Vest4
0.49
MVP
0.60
MPC
0.74
ClinPred
0.13
T
GERP RS
4.0
PromoterAI
-0.0085
Neutral
Varity_R
0.12
gMVP
0.38
Mutation Taster
=92/8
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.030
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs201825284; hg19: chr2-241660418; COSMIC: COSV57482468; COSMIC: COSV57482468; API